1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Congestive Heart Failure (CHF) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Injection 1.2.3 Capsule 1.2.4 Tablets 1.3 Market by Application 1.3.1 Global Congestive Heart Failure (CHF) Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Clinic 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Congestive Heart Failure (CHF) Market Perspective (2016-2027) 2.2 Congestive Heart Failure (CHF) Growth Trends by Regions 2.2.1 Congestive Heart Failure (CHF) Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Congestive Heart Failure (CHF) Historic Market Share by Regions (2016-2021) 2.2.3 Congestive Heart Failure (CHF) Forecasted Market Size by Regions (2022-2027) 2.3 Congestive Heart Failure (CHF) Industry Dynamic 2.3.1 Congestive Heart Failure (CHF) Market Trends 2.3.2 Congestive Heart Failure (CHF) Market Drivers 2.3.3 Congestive Heart Failure (CHF) Market Challenges 2.3.4 Congestive Heart Failure (CHF) Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Congestive Heart Failure (CHF) Players by Revenue 3.1.1 Global Top Congestive Heart Failure (CHF) Players by Revenue (2016-2021) 3.1.2 Global Congestive Heart Failure (CHF) Revenue Market Share by Players (2016-2021) 3.2 Global Congestive Heart Failure (CHF) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Congestive Heart Failure (CHF) Revenue 3.4 Global Congestive Heart Failure (CHF) Market Concentration Ratio 3.4.1 Global Congestive Heart Failure (CHF) Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Congestive Heart Failure (CHF) Revenue in 2020 3.5 Congestive Heart Failure (CHF) Key Players Head office and Area Served 3.6 Key Players Congestive Heart Failure (CHF) Product Solution and Service 3.7 Date of Enter into Congestive Heart Failure (CHF) Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Congestive Heart Failure (CHF) Breakdown Data by Type 4.1 Global Congestive Heart Failure (CHF) Historic Market Size by Type (2016-2021) 4.2 Global Congestive Heart Failure (CHF) Forecasted Market Size by Type (2022-2027) 5 Congestive Heart Failure (CHF) Breakdown Data by Application 5.1 Global Congestive Heart Failure (CHF) Historic Market Size by Application (2016-2021) 5.2 Global Congestive Heart Failure (CHF) Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Congestive Heart Failure (CHF) Market Size (2016-2027) 6.2 North America Congestive Heart Failure (CHF) Market Size by Type 6.2.1 North America Congestive Heart Failure (CHF) Market Size by Type (2016-2021) 6.2.2 North America Congestive Heart Failure (CHF) Market Size by Type (2022-2027) 6.2.3 North America Congestive Heart Failure (CHF) Market Size by Type (2016-2027) 6.3 North America Congestive Heart Failure (CHF) Market Size by Application 6.3.1 North America Congestive Heart Failure (CHF) Market Size by Application (2016-2021) 6.3.2 North America Congestive Heart Failure (CHF) Market Size by Application (2022-2027) 6.3.3 North America Congestive Heart Failure (CHF) Market Size by Application (2016-2027) 6.4 North America Congestive Heart Failure (CHF) Market Size by Country 6.4.1 North America Congestive Heart Failure (CHF) Market Size by Country (2016-2021) 6.4.2 North America Congestive Heart Failure (CHF) Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Congestive Heart Failure (CHF) Market Size (2016-2027) 7.2 Europe Congestive Heart Failure (CHF) Market Size by Type 7.2.1 Europe Congestive Heart Failure (CHF) Market Size by Type (2016-2021) 7.2.2 Europe Congestive Heart Failure (CHF) Market Size by Type (2022-2027) 7.2.3 Europe Congestive Heart Failure (CHF) Market Size by Type (2016-2027) 7.3 Europe Congestive Heart Failure (CHF) Market Size by Application 7.3.1 Europe Congestive Heart Failure (CHF) Market Size by Application (2016-2021) 7.3.2 Europe Congestive Heart Failure (CHF) Market Size by Application (2022-2027) 7.3.3 Europe Congestive Heart Failure (CHF) Market Size by Application (2016-2027) 7.4 Europe Congestive Heart Failure (CHF) Market Size by Country 7.4.1 Europe Congestive Heart Failure (CHF) Market Size by Country (2016-2021) 7.4.2 Europe Congestive Heart Failure (CHF) Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Congestive Heart Failure (CHF) Market Size (2016-2027) 8.2 Asia-Pacific Congestive Heart Failure (CHF) Market Size by Type 8.2.1 Asia-Pacific Congestive Heart Failure (CHF) Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Congestive Heart Failure (CHF) Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Congestive Heart Failure (CHF) Market Size by Type (2016-2027) 8.3 Asia-Pacific Congestive Heart Failure (CHF) Market Size by Application 8.3.1 Asia-Pacific Congestive Heart Failure (CHF) Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Congestive Heart Failure (CHF) Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Congestive Heart Failure (CHF) Market Size by Application (2016-2027) 8.4 Asia-Pacific Congestive Heart Failure (CHF) Market Size by Region 8.4.1 Asia-Pacific Congestive Heart Failure (CHF) Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Congestive Heart Failure (CHF) Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Congestive Heart Failure (CHF) Market Size (2016-2027) 9.2 Latin America Congestive Heart Failure (CHF) Market Size by Type 9.2.1 Latin America Congestive Heart Failure (CHF) Market Size by Type (2016-2021) 9.2.2 Latin America Congestive Heart Failure (CHF) Market Size by Type (2022-2027) 9.2.3 Latin America Congestive Heart Failure (CHF) Market Size by Type (2016-2027) 9.3 Latin America Congestive Heart Failure (CHF) Market Size by Application 9.3.1 Latin America Congestive Heart Failure (CHF) Market Size by Application (2016-2021) 9.3.2 Latin America Congestive Heart Failure (CHF) Market Size by Application (2022-2027) 9.3.3 Latin America Congestive Heart Failure (CHF) Market Size by Application (2016-2027) 9.4 Latin America Congestive Heart Failure (CHF) Market Size by Country 9.4.1 Latin America Congestive Heart Failure (CHF) Market Size by Country (2016-2021) 9.4.2 Latin America Congestive Heart Failure (CHF) Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Congestive Heart Failure (CHF) Market Size (2016-2027) 10.2 Middle East & Africa Congestive Heart Failure (CHF) Market Size by Type 10.2.1 Middle East & Africa Congestive Heart Failure (CHF) Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Congestive Heart Failure (CHF) Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Congestive Heart Failure (CHF) Market Size by Type (2016-2027) 10.3 Middle East & Africa Congestive Heart Failure (CHF) Market Size by Application 10.3.1 Middle East & Africa Congestive Heart Failure (CHF) Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Congestive Heart Failure (CHF) Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Congestive Heart Failure (CHF) Market Size by Application (2016-2027) 10.4 Middle East & Africa Congestive Heart Failure (CHF) Market Size by Country 10.4.1 Middle East & Africa Congestive Heart Failure (CHF) Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Congestive Heart Failure (CHF) Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Sanofi 11.1.1 Sanofi Company Details 11.1.2 Sanofi Business Overview 11.1.3 Sanofi Congestive Heart Failure (CHF) Introduction 11.1.4 Sanofi Revenue in Congestive Heart Failure (CHF) Business (2016-2021) 11.1.5 Sanofi Recent Development 11.2 Novartis 11.2.1 Novartis Company Details 11.2.2 Novartis Business Overview 11.2.3 Novartis Congestive Heart Failure (CHF) Introduction 11.2.4 Novartis Revenue in Congestive Heart Failure (CHF) Business (2016-2021) 11.2.5 Novartis Recent Development 11.3 Pfizer 11.3.1 Pfizer Company Details 11.3.2 Pfizer Business Overview 11.3.3 Pfizer Congestive Heart Failure (CHF) Introduction 11.3.4 Pfizer Revenue in Congestive Heart Failure (CHF) Business (2016-2021) 11.3.5 Pfizer Recent Development 11.4 Merck & Co 11.4.1 Merck & Co Company Details 11.4.2 Merck & Co Business Overview 11.4.3 Merck & Co Congestive Heart Failure (CHF) Introduction 11.4.4 Merck & Co Revenue in Congestive Heart Failure (CHF) Business (2016-2021) 11.4.5 Merck & Co Recent Development 11.5 AstraZeneca 11.5.1 AstraZeneca Company Details 11.5.2 AstraZeneca Business Overview 11.5.3 AstraZeneca Congestive Heart Failure (CHF) Introduction 11.5.4 AstraZeneca Revenue in Congestive Heart Failure (CHF) Business (2016-2021) 11.5.5 AstraZeneca Recent Development 11.6 GSK 11.6.1 GSK Company Details 11.6.2 GSK Business Overview 11.6.3 GSK Congestive Heart Failure (CHF) Introduction 11.6.4 GSK Revenue in Congestive Heart Failure (CHF) Business (2016-2021) 11.6.5 GSK Recent Development 11.7 Bristol-Myers Squibb 11.7.1 Bristol-Myers Squibb Company Details 11.7.2 Bristol-Myers Squibb Business Overview 11.7.3 Bristol-Myers Squibb Congestive Heart Failure (CHF) Introduction 11.7.4 Bristol-Myers Squibb Revenue in Congestive Heart Failure (CHF) Business (2016-2021) 11.7.5 Bristol-Myers Squibb Recent Development 11.8 Mylan 11.8.1 Mylan Company Details 11.8.2 Mylan Business Overview 11.8.3 Mylan Congestive Heart Failure (CHF) Introduction 11.8.4 Mylan Revenue in Congestive Heart Failure (CHF) Business (2016-2021) 11.8.5 Mylan Recent Development 11.9 Bausch Health 11.9.1 Bausch Health Company Details 11.9.2 Bausch Health Business Overview 11.9.3 Bausch Health Congestive Heart Failure (CHF) Introduction 11.9.4 Bausch Health Revenue in Congestive Heart Failure (CHF) Business (2016-2021) 11.9.5 Bausch Health Recent Development 11.10 Johnson & Johnson 11.10.1 Johnson & Johnson Company Details 11.10.2 Johnson & Johnson Business Overview 11.10.3 Johnson & Johnson Congestive Heart Failure (CHF) Introduction 11.10.4 Johnson & Johnson Revenue in Congestive Heart Failure (CHF) Business (2016-2021) 11.10.5 Johnson & Johnson Recent Development 11.11 Bayer 11.11.1 Bayer Company Details 11.11.2 Bayer Business Overview 11.11.3 Bayer Congestive Heart Failure (CHF) Introduction 11.11.4 Bayer Revenue in Congestive Heart Failure (CHF) Business (2016-2021) 11.11.5 Bayer Recent Development 11.12 Boehringer Inhelheim 11.12.1 Boehringer Inhelheim Company Details 11.12.2 Boehringer Inhelheim Business Overview 11.12.3 Boehringer Inhelheim Congestive Heart Failure (CHF) Introduction 11.12.4 Boehringer Inhelheim Revenue in Congestive Heart Failure (CHF) Business (2016-2021) 11.12.5 Boehringer Inhelheim Recent Development 11.13 Exelixis 11.13.1 Exelixis Company Details 11.13.2 Exelixis Business Overview 11.13.3 Exelixis Congestive Heart Failure (CHF) Introduction 11.13.4 Exelixis Revenue in Congestive Heart Failure (CHF) Business (2016-2021) 11.13.5 Exelixis Recent Development 11.14 Lunan Pharmaceutical 11.14.1 Lunan Pharmaceutical Company Details 11.14.2 Lunan Pharmaceutical Business Overview 11.14.3 Lunan Pharmaceutical Congestive Heart Failure (CHF) Introduction 11.14.4 Lunan Pharmaceutical Revenue in Congestive Heart Failure (CHF) Business (2016-2021) 11.14.5 Lunan Pharmaceutical Recent Development 11.15 Sinepharm 11.15.1 Sinepharm Company Details 11.15.2 Sinepharm Business Overview 11.15.3 Sinepharm Congestive Heart Failure (CHF) Introduction 11.15.4 Sinepharm Revenue in Congestive Heart Failure (CHF) Business (2016-2021) 11.15.5 Sinepharm Recent Development 11.16 CRC 11.16.1 CRC Company Details 11.16.2 CRC Business Overview 11.16.3 CRC Congestive Heart Failure (CHF) Introduction 11.16.4 CRC Revenue in Congestive Heart Failure (CHF) Business (2016-2021) 11.16.5 CRC Recent Development 11.17 Hai Ni Pharmaceutical 11.17.1 Hai Ni Pharmaceutical Company Details 11.17.2 Hai Ni Pharmaceutical Business Overview 11.17.3 Hai Ni Pharmaceutical Congestive Heart Failure (CHF) Introduction 11.17.4 Hai Ni Pharmaceutical Revenue in Congestive Heart Failure (CHF) Business (2016-2021) 11.17.5 Hai Ni Pharmaceutical Recent Development 11.18 Langtian 11.18.1 Langtian Company Details 11.18.2 Langtian Business Overview 11.18.3 Langtian Congestive Heart Failure (CHF) Introduction 11.18.4 Langtian Revenue in Congestive Heart Failure (CHF) Business (2016-2021) 11.18.5 Langtian Recent Development 11.18 NCPC .1 NCPC Company Details .2 NCPC Business Overview .3 NCPC Congestive Heart Failure (CHF) Introduction .4 NCPC Revenue in Congestive Heart Failure (CHF) Business (2016-2021) .5 NCPC Recent Development 11.20 Hayao 11.20.1 Hayao Company Details 11.20.2 Hayao Business Overview 11.20.3 Hayao Congestive Heart Failure (CHF) Introduction 11.20.4 Hayao Revenue in Congestive Heart Failure (CHF) Business (2016-2021) 11.20.5 Hayao Recent Development 11.21 Xinhua Group 11.21.1 Xinhua Group Company Details 11.21.2 Xinhua Group Business Overview 11.21.3 Xinhua Group Congestive Heart Failure (CHF) Introduction 11.21.4 Xinhua Group Revenue in Congestive Heart Failure (CHF) Business (2016-2021) 11.21.5 Xinhua Group Recent Development 11.22 Xudong Haipu Pharmaceutical 11.22.1 Xudong Haipu Pharmaceutical Company Details 11.22.2 Xudong Haipu Pharmaceutical Business Overview 11.22.3 Xudong Haipu Pharmaceutical Congestive Heart Failure (CHF) Introduction 11.22.4 Xudong Haipu Pharmaceutical Revenue in Congestive Heart Failure (CHF) Business (2016-2021) 11.22.5 Xudong Haipu Pharmaceutical Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Congestive Heart Failure (CHF) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Injection Table 3. Key Players of Capsule Table 4. Key Players of Tablets Table 5. Global Congestive Heart Failure (CHF) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Congestive Heart Failure (CHF) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Congestive Heart Failure (CHF) Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Congestive Heart Failure (CHF) Market Share by Regions (2016-2021) Table 9. Global Congestive Heart Failure (CHF) Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Congestive Heart Failure (CHF) Market Share by Regions (2022-2027) Table 11. Congestive Heart Failure (CHF) Market Trends Table 12. Congestive Heart Failure (CHF) Market Drivers Table 13. Congestive Heart Failure (CHF) Market Challenges Table 14. Congestive Heart Failure (CHF) Market Restraints Table 15. Global Congestive Heart Failure (CHF) Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Congestive Heart Failure (CHF) Market Share by Players (2016-2021) Table 17. Global Top Congestive Heart Failure (CHF) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Congestive Heart Failure (CHF) as of 2020) Table 18. Ranking of Global Top Congestive Heart Failure (CHF) Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Congestive Heart Failure (CHF) Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Congestive Heart Failure (CHF) Product Solution and Service Table 22. Date of Enter into Congestive Heart Failure (CHF) Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Congestive Heart Failure (CHF) Market Size by Type (2016-2021) (US$ Million) Table 25. Global Congestive Heart Failure (CHF) Revenue Market Share by Type (2016-2021) Table 26. Global Congestive Heart Failure (CHF) Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Congestive Heart Failure (CHF) Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Congestive Heart Failure (CHF) Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Congestive Heart Failure (CHF) Revenue Market Share by Application (2016-2021) Table 30. Global Congestive Heart Failure (CHF) Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Congestive Heart Failure (CHF) Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Congestive Heart Failure (CHF) Market Size by Type (2016-2021) (US$ Million) Table 33. North America Congestive Heart Failure (CHF) Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Congestive Heart Failure (CHF) Market Size by Application (2016-2021) (US$ Million) Table 35. North America Congestive Heart Failure (CHF) Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Congestive Heart Failure (CHF) Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Congestive Heart Failure (CHF) Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Congestive Heart Failure (CHF) Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Congestive Heart Failure (CHF) Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Congestive Heart Failure (CHF) Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Congestive Heart Failure (CHF) Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Congestive Heart Failure (CHF) Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Congestive Heart Failure (CHF) Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Congestive Heart Failure (CHF) Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Congestive Heart Failure (CHF) Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Congestive Heart Failure (CHF) Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Congestive Heart Failure (CHF) Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Congestive Heart Failure (CHF) Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Congestive Heart Failure (CHF) Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Congestive Heart Failure (CHF) Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Congestive Heart Failure (CHF) Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Congestive Heart Failure (CHF) Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Congestive Heart Failure (CHF) Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Congestive Heart Failure (CHF) Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Congestive Heart Failure (CHF) Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Congestive Heart Failure (CHF) Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Congestive Heart Failure (CHF) Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Congestive Heart Failure (CHF) Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Congestive Heart Failure (CHF) Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Congestive Heart Failure (CHF) Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Congestive Heart Failure (CHF) Market Size by Country (2022-2027) & (US$ Million) Table 62. Sanofi Company Details Table 63. Sanofi Business Overview Table 64. Sanofi Congestive Heart Failure (CHF) Product Table 65. Sanofi Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million) Table 66. Sanofi Recent Development Table 67. Novartis Company Details Table 68. Novartis Business Overview Table 69. Novartis Congestive Heart Failure (CHF) Product Table 70. Novartis Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million) Table 71. Novartis Recent Development Table 72. Pfizer Company Details Table 73. Pfizer Business Overview Table 74. Pfizer Congestive Heart Failure (CHF) Product Table 75. Pfizer Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million) Table 76. Pfizer Recent Development Table 77. Merck & Co Company Details Table 78. Merck & Co Business Overview Table 79. Merck & Co Congestive Heart Failure (CHF) Product Table 80. Merck & Co Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million) Table 81. Merck & Co Recent Development Table 82. AstraZeneca Company Details Table 83. AstraZeneca Business Overview Table 84. AstraZeneca Congestive Heart Failure (CHF) Product Table 85. AstraZeneca Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million) Table 86. AstraZeneca Recent Development Table 87. GSK Company Details Table 88. GSK Business Overview Table 89. GSK Congestive Heart Failure (CHF) Product Table 90. GSK Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million) Table 91. GSK Recent Development Table 92. Bristol-Myers Squibb Company Details Table 93. Bristol-Myers Squibb Business Overview Table 94. Bristol-Myers Squibb Congestive Heart Failure (CHF) Product Table 95. Bristol-Myers Squibb Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million) Table 96. Bristol-Myers Squibb Recent Development Table 97. Mylan Company Details Table 98. Mylan Business Overview Table 99. Mylan Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million) Table 100. Mylan Recent Development Table 101. Bausch Health Company Details Table 102. Bausch Health Business Overview Table 103. Bausch Health Congestive Heart Failure (CHF) Product Table 104. Bausch Health Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million) Table 105. Bausch Health Recent Development Table 106. Johnson & Johnson Company Details Table 107. Johnson & Johnson Business Overview Table 108. Johnson & Johnson Congestive Heart Failure (CHF) Product Table 109. Johnson & Johnson Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million) Table 110. Johnson & Johnson Recent Development Table 111. Bayer Company Details Table 112. Bayer Business Overview Table 113. Bayer Congestive Heart Failure (CHF) Product Table 114. Bayer Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million) Table 115. Bayer Recent Development Table 116. Boehringer Inhelheim Company Details Table 117. Boehringer Inhelheim Business Overview Table 118. Boehringer Inhelheim Congestive Heart Failure (CHF) Product Table 119. Boehringer Inhelheim Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million) Table 120. Boehringer Inhelheim Recent Development Table 121. Exelixis Company Details Table 122. Exelixis Business Overview Table 123. Exelixis Congestive Heart Failure (CHF) Product Table 124. Exelixis Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million) Table 125. Exelixis Recent Development Table 126. Lunan Pharmaceutical Company Details Table 127. Lunan Pharmaceutical Business Overview Table 128. Lunan Pharmaceutical Congestive Heart Failure (CHF) Product Table 129. Lunan Pharmaceutical Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million) Table 130. Lunan Pharmaceutical Recent Development Table 131. Sinepharm Company Details Table 132. Sinepharm Business Overview Table 133. Sinepharm Congestive Heart Failure (CHF) Product Table 134. Sinepharm Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million) Table 135. Sinepharm Recent Development Table 136. CRC Company Details Table 137. CRC Business Overview Table 138. CRC Congestive Heart Failure (CHF) Product Table 139. CRC Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million) Table 140. CRC Recent Development Table 141. Hai Ni Pharmaceutical Company Details Table 142. Hai Ni Pharmaceutical Business Overview Table 143. Hai Ni Pharmaceutical Congestive Heart Failure (CHF) Product Table 144. Hai Ni Pharmaceutical Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million) Table 145. Hai Ni Pharmaceutical Recent Development Table 146. Langtian Company Details Table 147. Langtian Business Overview Table 148. Langtian Congestive Heart Failure (CHF) Product Table 149. Langtian Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million) Table 150. Langtian Recent Development Table 151. NCPC Company Details Table 152. NCPC Business Overview Table 153. NCPC Congestive Heart Failure (CHF) Product Table 154. NCPC Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million) Table 155. NCPC Recent Development Table 156. Hayao Company Details Table 157. Hayao Business Overview Table 158. Hayao Congestive Heart Failure (CHF) Product Table 159. Hayao Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million) Table 160. Hayao Recent Development Table 161. Xinhua Group Company Details Table 162. Xinhua Group Business Overview Table 163. Xinhua Group Congestive Heart Failure (CHF) Product Table 164. Xinhua Group Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million) Table 165. Xinhua Group Recent Development Table 166. Xudong Haipu Pharmaceutical Company Details Table 167. Xudong Haipu Pharmaceutical Business Overview Table 168. Xudong Haipu Pharmaceutical Congestive Heart Failure (CHF) Product Table 169. Xudong Haipu Pharmaceutical Revenue in Congestive Heart Failure (CHF) Business (2016-2021) & (US$ Million) Table 170. Xudong Haipu Pharmaceutical Recent Development Table 171. Research Programs/Design for This Report Table 172. Key Data Information from Secondary Sources Table 173. Key Data Information from Primary Sources List of Figures Figure 1. Global Congestive Heart Failure (CHF) Market Share by Type: 2020 VS 2027 Figure 2. Injection Features Figure 3. Capsule Features Figure 4. Tablets Features Figure 5. Global Congestive Heart Failure (CHF) Market Share by Application: 2020 VS 2027 Figure 6. Hospital Case Studies Figure 7. Clinic Case Studies Figure 8. Congestive Heart Failure (CHF) Report Years Considered Figure 9. Global Congestive Heart Failure (CHF) Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Congestive Heart Failure (CHF) Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Congestive Heart Failure (CHF) Market Share by Regions: 2020 VS 2027 Figure 12. Global Congestive Heart Failure (CHF) Market Share by Regions (2022-2027) Figure 13. Global Congestive Heart Failure (CHF) Market Share by Players in 2020 Figure 14. Global Top Congestive Heart Failure (CHF) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Congestive Heart Failure (CHF) as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Congestive Heart Failure (CHF) Revenue in 2020 Figure 16. Global Congestive Heart Failure (CHF) Revenue Market Share by Type (2016-2021) Figure 17. Global Congestive Heart Failure (CHF) Revenue Market Share by Type (2022-2027) Figure 18. North America Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Congestive Heart Failure (CHF) Market Share by Type (2016-2027) Figure 20. North America Congestive Heart Failure (CHF) Market Share by Application (2016-2027) Figure 21. North America Congestive Heart Failure (CHF) Market Share by Country (2016-2027) Figure 22. United States Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Congestive Heart Failure (CHF) Market Share by Type (2016-2027) Figure 26. Europe Congestive Heart Failure (CHF) Market Share by Application (2016-2027) Figure 27. Europe Congestive Heart Failure (CHF) Market Share by Country (2016-2027) Figure 28. Germany Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Congestive Heart Failure (CHF) Market Share by Type (2016-2027) Figure 36. Asia-Pacific Congestive Heart Failure (CHF) Market Share by Application (2016-2027) Figure 37. Asia-Pacific Congestive Heart Failure (CHF) Market Share by Region (2016-2027) Figure 38. China Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Congestive Heart Failure (CHF) Market Share by Type (2016-2027) Figure 46. Latin America Congestive Heart Failure (CHF) Market Share by Application (2016-2027) Figure 47. Latin America Congestive Heart Failure (CHF) Market Share by Country (2016-2027) Figure 48. Mexico Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Congestive Heart Failure (CHF) Market Share by Type (2016-2027) Figure 52. Middle East & Africa Congestive Heart Failure (CHF) Market Share by Application (2016-2027) Figure 53. Middle East & Africa Congestive Heart Failure (CHF) Market Share by Country (2016-2027) Figure 54. Turkey Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Congestive Heart Failure (CHF) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Sanofi Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021) Figure 58. Novartis Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021) Figure 59. Pfizer Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021) Figure 60. Merck & Co Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021) Figure 61. AstraZeneca Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021) Figure 62. GSK Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021) Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021) Figure 64. Mylan Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021) Figure 65. Bausch Health Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021) Figure 66. Johnson & Johnson Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021) Figure 67. Bayer Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021) Figure 68. Boehringer Inhelheim Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021) Figure 69. Exelixis Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021) Figure 70. Lunan Pharmaceutical Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021) Figure 71. Sinepharm Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021) Figure 72. CRC Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021) Figure 73. Hai Ni Pharmaceutical Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021) Figure 74. Langtian Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021) Figure 75. NCPC Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021) Figure 76. Hayao Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021) Figure 77. Xinhua Group Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021) Figure 78. Xudong Haipu Pharmaceutical Revenue Growth Rate in Congestive Heart Failure (CHF) Business (2016-2021) Figure 79. Bottom-up and Top-down Approaches for This Report Figure 80. Data Triangulation Figure 81. Key Executives Interviewed

Sanofi Novartis Pfizer Merck & Co AstraZeneca GSK Bristol-Myers Squibb Mylan Bausch Health Johnson & Johnson Bayer Boehringer Inhelheim Exelixis Lunan Pharmaceutical Sinepharm CRC Hai Ni Pharmaceutical Langtian NCPC Hayao Xinhua Group Xudong Haipu Pharmaceutical